Collectively, the above results revealed that FGL2, but not FGL1, was unusually silenced in BLCA; downregulation of FGL2 was associated with an unfavorable prognosis, indicating that FGL2 might play an essential role in the progression of BLCA. This evidence concerns the gene FGL2 and bladder transitional cell carcinoma.